
Journal of Organometallic Chemistry p. 63 - 82 (1993)
Update date:2022-08-03
Topics:
Walter, Olaf
Klein, Thomas
Huttner, Gottfried
Zsolnai, Laszlo
The tripod ligand H3CC(CH2PPh2)3, 1, reacts with lithium metal to produce H3CC(CH2PPhLi)3, 2, in good yields.Compound 2 crystallizes in the form of 2*4THF*MeN(CH2CH2NMe2)2.The crystal structure of this adduct shows bridging as well as terminal phosphorous-coordination of lithium.Compound 2 reacts with electrophiles RX to give H3CC(CH2P(Ph)(R))3, 3 (R = H, Me, Et, iPr, CH2Ph, 3a-e).The transformation 1 <*> 2 <*> 3 can be performed in a one-pot reaction.While the chiral compounds 3 may be characterized as such, their reaction with (CH3CN)3Mo(CO)3 yields theeasy-to-characterize coordination compounds H3CC(CH3P(Ph)(R))3Mo(CO)3, 5.NMR analysis of 3 and 5 shows that from the two diastereomeric forms of 3 (the enantiomeric pair SSR/RRS and the pair SSS/RRR) only the SSR/RRS-diastereomer is formed with R = CH2Ph (3e, 5e).In the other cases (R = H, Me, Et, iPr) a statistical 3:1 mixture of the two diastereomers is formed.These findings are further corroborated by X-ray analyses of H3CC(CH2P(Ph)(Et))3Mo(CO)3, 5c, and H3CC(CH2P(Ph)(CH2Ph))3Mo(CO)3, 5e.The remarkable facts reported in this paper are the ease with which the chiral tripod ligands H3CC(CH2P(Ph)(R))3, 3, are prepared, and the evidence that their formation may well involve diastereoselective control.
View Morewebsite:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Contact:0550-7041128 0550-7090578
Address:Wangdian Street,Xinjie Town
Guangzhou Flower's Song Fine Chemical CO,. Ltd
Contact:+86-20-87475199
Address:No.12, Fenghuang 3 Road, Jiulong Industrial Park, Luogang District, Guangzhou. China
jintan yufan Medicine Raw materials Co.,Ltd.(expird)
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
Tianjin Realet Chemical Technology Co.,Ltd.
website:http://www.realetchem.com
Contact:+86-022-58788819
Address:shuanggang industrial park
Doi:10.1016/S0040-4039(01)01825-1
(2001)Doi:10.1039/c3ra46270f
(2014)Doi:10.1080/00397910903340637
(2010)Doi:10.1016/0223-5234(93)90114-T
(1993)Doi:10.1055/s-1993-26037
(1993)Doi:10.7164/antibiotics.46.1919
(1993)